Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease-Reference-Cited by-同舟云学术

Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease

Published:2021-02-08 Issue: Volume: Page:
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Kim Hyung Woo, ,Park Jung Tak,Joo Young Su,Kang Shin Chan,Lee Jee Young,Lee Sangmi,Chang Tae Ik,Kang Ea Wha,Ryu Dong-Ryeol,Yoo Tae-Hyun,Chin Ho Jun,Kang Shin-Wook,Han Seung Hyeok^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-020-00930-x.pdf

Reference36 articles.

1. Becker GJ, Wheeler DC, De Zeeuw D, Fujita T, Furth SL, Holdaas H et al (2012) Kidney disease: improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2(5):337–414

2. Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI et al (2014) Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med 371(24):2255–2266

3. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC (2005) Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 16(4):1061–1068

4. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S et al (1995) A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48(5):1600–1604

5. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C et al (1989) A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320(1):8–13

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?;Biomedicines;2024-06-04

2. The diversity of peripheral blood T cells and myeloid-derived suppressor cells in patients with idiopathic membranous nephropathy;Clinical Nephrology;2024-06-01

3. Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030;Renal Failure;2024-03-14

4. Prediction of chronic kidney disease progression using recurrent neural network and electronic health records;Scientific Reports;2023-12-13

5. Genetic evidence supporting the causal role of gut microbiota in chronic kidney disease and chronic systemic inflammation in CKD: a bilateral two-sample Mendelian randomization study;Frontiers in Immunology;2023-11-02